MSH|^~\&|LAB|SMH|||202003041354||ORU^R01|4180290|D|2.3|||AL|NE
PID|1||SM00044280|SM44111|LABTEST^AIR^PRESTO||19870323|M||||||||||SM005225/18|9875450974
OBR|1|40119^LAB|00030257^0403:H00003R^LAB^040320:H3^40119|210.0000^MALARIA^Malaria Profile^^^XXX-1339||202003041324|202003041324|||||||202003041324||||||||||LAB|I||||
OBR|2|40119^LAB|00030257^0403:H00003R^LAB^040320:H3^40119|210.0550^MALNAT^Malaria NAT^^^||202003041324|202003041324|||||||202003041324||||||||||LAB|F||||
OBX|1|ST|210.0560^MALNAT R^Malaria NAT^^^|1|Positive^^N||Negative|H||A^S|F|||202003041354
NTE|1||Further testing to follow.  This assay does not distinguish
NTE|2||between residual nucleic acid (which may persist after
NTE|3||adequate treatment), and viable intact parasites. This assay
NTE|4||may detect low-grade asymptomatic parasitemia from
NTE|5||individuals exposed to malaria-endemic areas.